Request for Covid-19 Impact Assessment of this Report
The United States Microneedles for Trans & Intradermal Drug Delivery market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Microneedles for Trans & Intradermal Drug Delivery market, reaching US$ million by the year 2028. As for the Europe Microneedles for Trans & Intradermal Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Microneedles for Trans & Intradermal Drug Delivery players cover Becton Dickinson, Nanopass Technologies, Radius Health, and Clearside Biomedical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Microneedles for Trans & Intradermal Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Drugs
Vaccines
Proteins
Peptides
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Microneedles for Trans & Intradermal Drug Delivery by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Microneedles for Trans & Intradermal Drug Delivery by Country/Region, 2017, 2022 & 2028
2.2 Microneedles for Trans & Intradermal Drug Delivery Segment by Type
2.2.1 Solid Microneedles
2.2.2 Hollow Microneedles
2.2.3 Dissolvable Microneedles
2.3 Microneedles for Trans & Intradermal Drug Delivery Sales by Type
2.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2022)
2.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue and Market Share by Type (2017-2022)
2.3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Type (2017-2022)
2.4 Microneedles for Trans & Intradermal Drug Delivery Segment by Application
2.4.1 Drugs
2.4.2 Vaccines
2.4.3 Proteins
2.4.4 Peptides
2.4.5 Others
2.5 Microneedles for Trans & Intradermal Drug Delivery Sales by Application
2.5.1 Global Microneedles for Trans & Intradermal Drug Delivery Sale Market Share by Application (2017-2022)
2.5.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue and Market Share by Application (2017-2022)
2.5.3 Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Application (2017-2022)
3 Global Microneedles for Trans & Intradermal Drug Delivery by Company
3.1 Global Microneedles for Trans & Intradermal Drug Delivery Breakdown Data by Company
3.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales by Company (2020-2022)
3.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Company (2020-2022)
3.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue by Company (2020-2022)
3.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Company (2020-2022)
3.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Company (2020-2022)
3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Company
3.4 Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Location Distribution
3.4.2 Players Microneedles for Trans & Intradermal Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Microneedles for Trans & Intradermal Drug Delivery by Geographic Region
4.1 World Historic Microneedles for Trans & Intradermal Drug Delivery Market Size by Geographic Region (2017-2022)
4.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue by Geographic Region
4.2 World Historic Microneedles for Trans & Intradermal Drug Delivery Market Size by Country/Region (2017-2022)
4.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales by Country/Region (2017-2022)
4.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue by Country/Region
4.3 Americas Microneedles for Trans & Intradermal Drug Delivery Sales Growth
4.4 APAC Microneedles for Trans & Intradermal Drug Delivery Sales Growth
4.5 Europe Microneedles for Trans & Intradermal Drug Delivery Sales Growth
4.6 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Growth
5 Americas
5.1 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Country
5.1.1 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022)
5.1.2 Americas Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022)
5.2 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Type
5.3 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Region
6.1.1 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022)
6.1.2 APAC Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022)
6.2 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Type
6.3 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Microneedles for Trans & Intradermal Drug Delivery by Country
7.1.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022)
7.1.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022)
7.2 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type
7.3 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery by Country
8.1.1 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022)
8.1.2 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022)
8.2 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type
8.3 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Microneedles for Trans & Intradermal Drug Delivery
10.3 Manufacturing Process Analysis of Microneedles for Trans & Intradermal Drug Delivery
10.4 Industry Chain Structure of Microneedles for Trans & Intradermal Drug Delivery
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Microneedles for Trans & Intradermal Drug Delivery Distributors
11.3 Microneedles for Trans & Intradermal Drug Delivery Customer
12 World Forecast Review for Microneedles for Trans & Intradermal Drug Delivery by Geographic Region
12.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size Forecast by Region
12.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Region (2023-2028)
12.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Type
12.7 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Application
13 Key Players Analysis
13.1 Becton Dickinson
13.1.1 Becton Dickinson Company Information
13.1.2 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Offered
13.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Becton Dickinson Main Business Overview
13.1.5 Becton Dickinson Latest Developments
13.2 Nanopass Technologies
13.2.1 Nanopass Technologies Company Information
13.2.2 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Offered
13.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Nanopass Technologies Main Business Overview
13.2.5 Nanopass Technologies Latest Developments
13.3 Radius Health
13.3.1 Radius Health Company Information
13.3.2 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Offered
13.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Radius Health Main Business Overview
13.3.5 Radius Health Latest Developments
13.4 Clearside Biomedical
13.4.1 Clearside Biomedical Company Information
13.4.2 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Offered
13.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Clearside Biomedical Main Business Overview
13.4.5 Clearside Biomedical Latest Developments
13.5 Dr. Prausnitz Group
13.5.1 Dr. Prausnitz Group Company Information
13.5.2 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Offered
13.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Dr. Prausnitz Group Main Business Overview
13.5.5 Dr. Prausnitz Group Latest Developments
13.6 Zosano Pharma
13.6.1 Zosano Pharma Company Information
13.6.2 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Offered
13.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Zosano Pharma Main Business Overview
13.6.5 Zosano Pharma Latest Developments
13.7 Corium International
13.7.1 Corium International Company Information
13.7.2 Corium International Microneedles for Trans & Intradermal Drug Delivery Product Offered
13.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Corium International Main Business Overview
13.7.5 Corium International Latest Developments
13.8 Circassia
13.8.1 Circassia Company Information
13.8.2 Circassia Microneedles for Trans & Intradermal Drug Delivery Product Offered
13.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Circassia Main Business Overview
13.8.5 Circassia Latest Developments
13.9 Valeritas, Inc.
13.9.1 Valeritas, Inc. Company Information
13.9.2 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Offered
13.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Valeritas, Inc. Main Business Overview
13.9.5 Valeritas, Inc. Latest Developments
13.10 BD Medical
13.10.1 BD Medical Company Information
13.10.2 BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Offered
13.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 BD Medical Main Business Overview
13.10.5 BD Medical Latest Developments
14 Research Findings and Conclusion
Table 1. Microneedles for Trans & Intradermal Drug Delivery Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Microneedles for Trans & Intradermal Drug Delivery Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Solid Microneedles
Table 4. Major Players of Hollow Microneedles
Table 5. Major Players of Dissolvable Microneedles
Table 6. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 7. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 8. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & ($ million)
Table 9. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2022)
Table 10. Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 12. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 13. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022)
Table 14. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2022)
Table 15. Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Company (2020-2022) & (K Units)
Table 17. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Company (2020-2022)
Table 18. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Company (2020-2022)
Table 20. Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Producing Area Distribution and Sales Area
Table 22. Players Microneedles for Trans & Intradermal Drug Delivery Products Offered
Table 23. Microneedles for Trans & Intradermal Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share Geographic Region (2017-2022)
Table 28. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country/Region (2017-2022)
Table 32. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 35. Americas Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 36. Americas Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 38. Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 39. Americas Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 40. Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 41. Americas Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 42. APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 43. APAC Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2017-2022)
Table 44. APAC Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2017-2022)
Table 46. APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 47. APAC Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 48. APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 49. APAC Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 50. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 51. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 52. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 54. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 55. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 56. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 57. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Microneedles for Trans & Intradermal Drug Delivery
Table 67. Key Market Challenges & Risks of Microneedles for Trans & Intradermal Drug Delivery
Table 68. Key Industry Trends of Microneedles for Trans & Intradermal Drug Delivery
Table 69. Microneedles for Trans & Intradermal Drug Delivery Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Microneedles for Trans & Intradermal Drug Delivery Distributors List
Table 72. Microneedles for Trans & Intradermal Drug Delivery Customer List
Table 73. Global Microneedles for Trans & Intradermal Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Forecast by Region
Table 75. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Microneedles for Trans & Intradermal Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Microneedles for Trans & Intradermal Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Microneedles for Trans & Intradermal Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Microneedles for Trans & Intradermal Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Microneedles for Trans & Intradermal Drug Delivery Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Microneedles for Trans & Intradermal Drug Delivery Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Forecast by Application (2023-2028)
Table 93. Becton Dickinson Basic Information, Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 94. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 95. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Becton Dickinson Main Business
Table 97. Becton Dickinson Latest Developments
Table 98. Nanopass Technologies Basic Information, Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 99. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 100. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Nanopass Technologies Main Business
Table 102. Nanopass Technologies Latest Developments
Table 103. Radius Health Basic Information, Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 104. Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 105. Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Radius Health Main Business
Table 107. Radius Health Latest Developments
Table 108. Clearside Biomedical Basic Information, Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 109. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 110. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Clearside Biomedical Main Business
Table 112. Clearside Biomedical Latest Developments
Table 113. Dr. Prausnitz Group Basic Information, Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 114. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 115. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Dr. Prausnitz Group Main Business
Table 117. Dr. Prausnitz Group Latest Developments
Table 118. Zosano Pharma Basic Information, Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 119. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 120. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Zosano Pharma Main Business
Table 122. Zosano Pharma Latest Developments
Table 123. Corium International Basic Information, Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 124. Corium International Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 125. Corium International Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Corium International Main Business
Table 127. Corium International Latest Developments
Table 128. Circassia Basic Information, Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 129. Circassia Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 130. Circassia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Circassia Main Business
Table 132. Circassia Latest Developments
Table 133. Valeritas, Inc. Basic Information, Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 134. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 135. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Valeritas, Inc. Main Business
Table 137. Valeritas, Inc. Latest Developments
Table 138. BD Medical Basic Information, Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 139. BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 140. BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 141. BD Medical Main Business
Table 142. BD Medical Latest Developments
List of Figures
Figure 1. Picture of Microneedles for Trans & Intradermal Drug Delivery
Figure 2. Microneedles for Trans & Intradermal Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Microneedles for Trans & Intradermal Drug Delivery Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Solid Microneedles
Figure 10. Product Picture of Hollow Microneedles
Figure 11. Product Picture of Dissolvable Microneedles
Figure 12. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type in 2021
Figure 13. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2022)
Figure 14. Microneedles for Trans & Intradermal Drug Delivery Consumed in Drugs
Figure 15. Global Microneedles for Trans & Intradermal Drug Delivery Market: Drugs (2017-2022) & (K Units)
Figure 16. Microneedles for Trans & Intradermal Drug Delivery Consumed in Vaccines
Figure 17. Global Microneedles for Trans & Intradermal Drug Delivery Market: Vaccines (2017-2022) & (K Units)
Figure 18. Microneedles for Trans & Intradermal Drug Delivery Consumed in Proteins
Figure 19. Global Microneedles for Trans & Intradermal Drug Delivery Market: Proteins (2017-2022) & (K Units)
Figure 20. Microneedles for Trans & Intradermal Drug Delivery Consumed in Peptides
Figure 21. Global Microneedles for Trans & Intradermal Drug Delivery Market: Peptides (2017-2022) & (K Units)
Figure 22. Microneedles for Trans & Intradermal Drug Delivery Consumed in Others
Figure 23. Global Microneedles for Trans & Intradermal Drug Delivery Market: Others (2017-2022) & (K Units)
Figure 24. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2022)
Figure 25. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application in 2021
Figure 26. Microneedles for Trans & Intradermal Drug Delivery Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Company in 2021
Figure 28. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Geographic Region in 2021
Figure 30. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2017-2022)
Figure 31. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country/Region in 2021
Figure 32. Americas Microneedles for Trans & Intradermal Drug Delivery Sales 2017-2022 (K Units)
Figure 33. Americas Microneedles for Trans & Intradermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 34. APAC Microneedles for Trans & Intradermal Drug Delivery Sales 2017-2022 (K Units)
Figure 35. APAC Microneedles for Trans & Intradermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 36. Europe Microneedles for Trans & Intradermal Drug Delivery Sales 2017-2022 (K Units)
Figure 37. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 40. Americas Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country in 2021
Figure 41. Americas Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country in 2021
Figure 42. United States Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region in 2021
Figure 47. APAC Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Regions in 2021
Figure 48. China Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country in 2021
Figure 55. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country in 2021
Figure 56. Germany Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country in 2021
Figure 63. Egypt Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Microneedles for Trans & Intradermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Microneedles for Trans & Intradermal Drug Delivery in 2021
Figure 69. Manufacturing Process Analysis of Microneedles for Trans & Intradermal Drug Delivery
Figure 70. Industry Chain Structure of Microneedles for Trans & Intradermal Drug Delivery
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...